financetom
Business
financetom
/
Business
/
PRESS DIGEST-Wall Street Journal - October 27
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST-Wall Street Journal - October 27
Oct 26, 2025 10:55 PM

The following are the top stories in the Wall Street Journal.

Reuters has not verified these stories and does not vouch for

their accuracy.

- Novartis is acquiring Avidity Biosciences ( RNA )

in a $12 billion deal that the Swiss drugmaker said would

further boost its long-term focus on treating neuromuscular

disorders.

- Roughly 3,200 striking St. Louis-area Boeing ( BA )

workers will stay on the picket line after members rejected a

modified contract proposal for a fourth time.

- Australia's consumer watchdog is suing Microsoft ( MSFT ),

alleging the U.S. tech giant misled its 2.7 million customers by

making it difficult for them to avoid paying for new

artificial-intelligence services.

- HSBC Holdings ( HSBC ) is booking a provision of $1.1

billion for a lawsuit in Luxembourg related to Bernard Madoff's

multibillion-dollar Ponzi scheme, one of the largest financial

frauds in American history.

- The U.S. will impose an additional 10% tariff on Canada,

President Donald Trump said on Saturday, a punitive measure in

response to an ad campaign that he said misrepresented comments

by former President Ronald Reagan.

- Movie and television producer Taylor Sheridan, known for

hits including "Yellowstone," "Tulsa King" and "Landman," has

signed a deal to join NBCUniversal after his contract

with Paramount expires.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teva Pharmaceutical third-quarter profit, revenue top estimates
Teva Pharmaceutical third-quarter profit, revenue top estimates
Nov 6, 2024
JERUSALEM, Nov 6 (Reuters) - Teva Pharmaceutical Industries reported a larger than expected rise in third-quarter profit, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington's disease. The world's largest generic drugmaker said on Wednesday it earned 69 cents per diluted share excluding one-time items in the July-September quarter, up from 60 cents...
ODP's Q3 Adjusted Earnings, Sales Fall
ODP's Q3 Adjusted Earnings, Sales Fall
Nov 6, 2024
07:22 AM EST, 11/06/2024 (MT Newswires) -- ODP (ODP) reported Q3 adjusted earnings from continuing operations Wednesday of $0.71 per diluted share, down from $2.17 a year earlier. Three analysts polled by Capital IQ expected $1.60. Sales for the quarter ended Sept. 30 were $1.78 billion, down from $2.01 billion a year earlier. Three analysts surveyed by Capital IQ expected...
Aurora Cannabis Q2 Profit Advances
Aurora Cannabis Q2 Profit Advances
Nov 6, 2024
07:25 AM EST, 11/06/2024 (MT Newswires) -- Aurora Cannabis ( ACB ) on Wednesday said second-quarter profit and revenue rose. Net income from continuing operations climbed to $1.7 million in the second quarter from $0.4 million in the same period last year. Total net revenue climbed 29% to $81.1 million from $63.1 million. The increase was mainly due to a...
Explainer-How Trump's second administration affects business: Musk, tariffs and more
Explainer-How Trump's second administration affects business: Musk, tariffs and more
Nov 6, 2024
(Reuters) - Donald Trump's return to the White House after winning the Nov. 5 U.S. presidential election may reshape American business. Much depends on whom he appoints as deputies and cabinet members, including the role of Tesla CEO Elon Musk, and what tariffs he enacts. Following are some major issues and sectors to watch: WHAT ROLE WILL ELON MUSK PLAY? After...
Copyright 2023-2026 - www.financetom.com All Rights Reserved